Monoamine Transporter and Receptor Interaction Profiles in Vitro Predict Reported Human Doses of Novel Psychoactive Stimulants and Psychedelics

The International Journal of Neuropsychopharmacology
Dino Luethi, Matthias E Liechti

Abstract

Pharmacological profiles of new psychoactive substances can be established rapidly in vitro and provide information on potential psychoactive effects in humans. The present study investigated whether specific in vitro monoamine transporter and receptor interactions can predict effective psychoactive doses in humans. We correlated previously assessed in vitro data of stimulants and psychedelics with human doses that are reported on the Internet and in books. For stimulants, dopamine and norepinephrine transporter inhibition potency was positively correlated with human doses, whereas serotonin transporter inhibition potency was inversely correlated with human doses. Serotonin 5-hydroxytryptamine-2A (5-HT2A) and 5-HT2C receptor affinity was significantly correlated with psychedelic doses, but 5-HT1A receptor affinity and 5-HT2A and 5-HT2B receptor activation potency were not. The rapid assessment of in vitro pharmacological profiles of new psychoactive substances can help to predict psychoactive doses and effects in humans and facilitate the appropriate scheduling of new psychoactive substances.

References

Jul 1, 1991·Trends in Neurosciences·M J KuharJ W Boja
Dec 1, 1990·British Journal of Clinical Pharmacology·R BrenneisenP Kalix
May 18, 1999·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·E Gouzoulis-MayfrankH Sass
Jun 11, 2002·British Journal of Pharmacology·Claudio Acuña-CastilloJ Pablo Huidobro-Toro
Oct 18, 2003·Drug and Alcohol Dependence·Manuel Tancer, Chris-Ellyn Johanson
Nov 13, 2003·European Journal of Pharmacology·Richard B Rothman, Michael H Baumann
Feb 6, 2004·Pharmacology & Therapeutics·David E Nichols
Jan 29, 2005·The Journal of Pharmacology and Experimental Therapeutics·S WeeW L Woolverton
Jul 11, 2006·Pharmacology, Biochemistry, and Behavior·Sunmee Wee, William L Woolverton
Dec 16, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Michael H BaumannNicholas V Cozzi
Mar 1, 2012·PloS One·Erich StuderusFranz X Vollenweider
Aug 18, 2012·British Journal of Pharmacology·L D SimmlerM E Liechti
Dec 25, 2012·European Journal of Pharmacology·Les IversenBryan L Roth
Feb 4, 2014·Biochemical Pharmacology·Linda D SimmlerMatthias E Liechti
Jul 24, 2014·Journal of Psychopharmacology·Yasmin SchmidMatthias E Liechti
Jan 28, 2015·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Anna RickliMatthias E Liechti
Mar 15, 2015·British Journal of Pharmacology·Anna RickliMatthias E Liechti
Nov 7, 2015·BioMed Research International·Débora GonzálezMagí Farré
Dec 10, 2015·The Journal of Pharmacology and Experimental Therapeutics·Julie A SuyamaMatthew L Banks
Feb 5, 2016·Pharmacological Reviews·David E Nichols
May 21, 2016·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Esther PapaseitMagí Farré
May 25, 2016·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Anna RickliMatthias E Liechti
Feb 16, 2017·Clinical Pharmacokinetics·Patrick C DolderMatthias E Liechti
Apr 27, 2017·Journal of Psychopharmacology·Patrick Vizeli, Matthias E Liechti
Apr 28, 2017·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Matthias E Liechti
Jul 20, 2017·Neuropharmacology·Dino LuethiMatthias E Liechti
Aug 2, 2017·Neuropharmacology·Dino LuethiMatthias E Liechti
Aug 22, 2017·Neuropharmacology·Dino LuethiMatthias E Liechti
Sep 25, 2017·Frontiers in Pharmacology·Patrick C DolderMatthias E Liechti
Dec 12, 2017·European Journal of Pharmacology·Dino LuethiMatthias E Liechti

❮ Previous
Next ❯

Citations

Sep 5, 2019·British Journal of Clinical Pharmacology·Katharina Elisabeth GrafingerEvangelia Liakoni
Jan 11, 2019·PloS One·Miguel Toro-SazoBruce K Cassels
May 13, 2020·Annals of the New York Academy of Sciences·F Ivy CarrollP Anantha Reddy
Nov 12, 2019·Frontiers in Psychiatry·Patrick Vizeli, Matthias E Liechti
Feb 11, 2020·Frontiers in Pharmacology·Miguel Reyes-ParadaBruce K Cassels
Dec 19, 2019·Frontiers in Pharmacology·Karolina E KolaczynskaMatthias E Liechti
Apr 7, 2020·Archives of Toxicology·Dino Luethi, Matthias E Liechti
Mar 27, 2019·Psychopharmacology·Ana Belen Lopez-Rodriguez, Maria-Paz Viveros
Dec 10, 2020·International Journal of Molecular Sciences·Sara MalacaMarilyn A Huestis
Dec 23, 2020·International Journal of Molecular Sciences·Veronica CocchiMonia Lenzi
May 16, 2020·Acta Pharmaceutica : a Quarterly Journal of Croatian Pharmaceutical Society and Slovenian Pharmaceutical Society, Dealing with All Branches of Pharmacy and Allied Sciences·Anna Welz, Marcin Koba
Apr 1, 2021·British Journal of Pharmacology·James R Docherty, Hadeel A Alsufyani
Aug 8, 2021·International Journal of Molecular Sciences·Karolina E KolaczynskaMatthias E Liechti
Aug 17, 2021·Journal of Clinical Pharmacology·James R Docherty, Hadeel A Alsufyani
Nov 20, 2021·Journal of Neurochemistry·Samuel T SlocumBryan L Roth

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
Anna RickliMatthias E Liechti
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
Iain Brew
© 2022 Meta ULC. All rights reserved